...
首页> 外文期刊>Biological & pharmaceutical bulletin >Transcriptome Analysis of Nine Tissues to Discover Genes Involved in the Biosynthesis of Active Ingredients in Sophora flavescens
【24h】

Transcriptome Analysis of Nine Tissues to Discover Genes Involved in the Biosynthesis of Active Ingredients in Sophora flavescens

机译:九个组织的转录组分析,以发现涉及苦参中活性成分生物合成的基因

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Sophora flavescens AITON (kurara) has long been used to treat various diseases. Although several research findings revealed the biosynthetic pathways of its characteristic chemical components as represented by matrine, insufficient analysis of transeriptome data hampered in-depth analysis of the underlying putative genes responsible for the biosynthesis of pharmaceutical chemical components. In this study, more than 200 million fastq format reads were generated by Illumina's next-generation sequencing approach using nine types of tissue from S. flavescens, followed by CLC de novo assembly, ultimately yielding 83325 contigs in total. By mapping the reads back to the contigs, reads per kilobase of the transcript per million mapped reads values were calculated to demonstrate gene expression levels, and overrepresented gene ontology terms were evaluated using Fisher's exact test. In search of the putative genes relevant to essential metabolic pathways, all 1350 unique enzyme commission numbers were used to map pathways against the Kyoto Encyclopedia of Genes and Genomes. By analyzing expression patterns, we proposed some candidate genes involved in the biosynthesis of isoflavonoids and quinolizidine alkaloids. Adopting RNA-Seq analysis, we obtained substantially credible contigs for downstream work. The preferential expression of the gene for putative lysine/ornithine decarboxylase committed in the initial step of matrine biosynthesis in leaves and stems was confirmed in semi-quantitative polymerase chain reaction (PCR) analysis. The findings in this report may serve as a stepping-stone for further research into this promising medicinal plant.
机译:苦参(Sophora flavescens)AITON(kurara)长期以来一直用于治疗各种疾病。尽管一些研究发现揭示了以苦参碱为代表的其特征化学成分的生物合成途径,但对透核组数据的分析不足阻碍了对负责药物化学成分生物合成的潜在推定基因的深入分析。在这项研究中,Illumina的下一代测序方法使用了来自苦参链球菌的9种组织,随后进行了CLC de novo组装,产生了超过2亿个fastq格式的读数,最终总共产生了83325个重叠群。通过将读段映射回重叠群,计算每百万碱基对读段的转录本的每千个碱基的读段,以证明基因表达水平,并使用Fisher精确检验来评估过度代表的基因本体术语。为了寻找与基本代谢途径有关的推定基因,使用了所有1350个独特的酶委员会编号来针对京都议定书基因和基因组百科全书绘制途径。通过分析表达模式,我们提出了一些参与异黄酮和喹喔啉生物碱生物合成的候选基因。通过RNA-Seq分析,我们获得了可信赖的重叠群用于下游工作。在半定量聚合酶链反应(PCR)分析中证实了在苦参碱生物合成起始阶段在叶和茎中所承诺的赖氨酸/鸟氨酸脱羧酶基因的优先表达。本报告中的发现可作为对该有前景的药用植物进行进一步研究的垫脚石。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号